Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Vor Biopharma Inc.

    NASDAQ: VOR · Real-Time Price · USD
    0.22
    -0.00 (-1.61%)
    At close: Jun 06, 2025, 3:59 PM
    0.22
    1.31%
    After-hours: Jun 06, 2025, 05:38 PM EDT

    Vor Biopharma Statistics

    Share Statistics

    Vor Biopharma has 124.96M shares outstanding. The number of shares has increased by 82.91% in one year.

    Shares Outstanding

    n/a
    		 124.96M

    Shares Change (YoY)

    n/a
    		 82.91%

    Shares Change (QoQ)

    n/a
    		 81.8%

    Owned by Institutions (%)

    n/a
    		 89.02%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 128,716

    FTD / Avg. Volume

    n/a
    		 6.48%

    Short Selling Information

    The latest short interest is 2.76M, so 2.21% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.76M

    Short % of Shares Out

    n/a
    		 2.21%

    Short % of Float

    n/a
    		 6.06%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.65 and the forward PE ratio is -0.52. Vor Biopharma's PEG ratio is 0.23.

    PE Ratio

    n/a
    		 -0.65

    Forward PE

    n/a
    		 -0.52

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0.79

    P/FCF Ratio

    n/a
    		 -0.76

    PEG Ratio

    n/a
    		 0.23
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Vor Biopharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.19, with a Debt / Equity ratio of 0.33.

    Current Ratio

    n/a
    		 5.19

    Quick Ratio

    n/a
    		 5.19

    Debt / Equity

    n/a
    		 0.33

    Debt / EBITDA

    n/a
    		 -0.28

    Debt / FCF

    n/a
    		 -0.32

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-735,308.18

    Employee Count

    n/a
    		 159

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -82.54% in the last 52 weeks. The beta is -0.51, so Vor Biopharma's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.51

    52-Week Price Change

    n/a
    		 -82.54%

    50-Day Moving Average

    n/a
    		 0.47

    200-Day Moving Average

    n/a
    		 0.86

    Relative Strength Index (RSI)

    n/a
    		 34.16

    Average Volume (20 Days)

    n/a
    		 1,987,496

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -121.19M

    Net Income

    n/a
    		 -116.91M

    EBITDA

    n/a
    		 -113.39M

    EBIT

    n/a
    		 -116.91M

    Earnings Per Share (EPS)

    n/a
    		 -1.7
    Full Income Statement

    Balance Sheet

    The company has 81.95M in cash and 31.83M in debt, giving a net cash position of 50.12M.

    Cash & Cash Equivalents

    n/a
    		 81.95M

    Total Debt

    n/a
    		 31.83M

    Net Cash

    n/a
    		 50.12M

    Retained Earnings

    n/a
    		 -456.99M

    Total Assets

    n/a
    		 109.31M

    Working Capital

    n/a
    		 48.12M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -99.66M and capital expenditures -229K, giving a free cash flow of -99.89M.

    Operating Cash Flow

    n/a
    		 -99.66M

    Capital Expenditures

    n/a
    		 -229K

    Free Cash Flow

    n/a
    		 -99.89M

    FCF Per Share

    n/a
    		 -1.45
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    VOR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for VOR is $5.5, which is 2400% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $5.5

    Price Target Difference

    n/a
    		 2400%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -9.12

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist